Early response detection in systemic lung cancer treatment using cell-free methylated SHOX2 (mSHOX2) plasma DNA
Bernd Schmidt (Halle, Germany), Bernd Schmidt, Julia Beyer, Dimo Dietrich, Nina Lambrecht, Michael Fleischhacker
|  |
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Elena Karampini (London, United Kingdom), Elena Karampini, Hassan Farah, Nahid Kamal, Paul Cane, Jane Moorhead, Sabine Pomplun, Juliet King, Tariq Sethi, James Spicer, Frank McCaughan
| |
In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients
Bernd Schmidt (Halle, Germany), Michael Fleichhacker, Hubertus Rolke, Clemens Oerding, Gerit Theil, Bettina Wollschläger, Bernd Schmidt
| |
Peripheral blood lymphocytes indicate an immunosuppressive status in lung cancer
María del Mar Valenzuela-Membrives (Granada, Spain), María del Mar Valenzuela Membrives, Abel Sanchez- Palencia Ramos, Francisco Perea García, Francisco Ruiz Cabello, Antonio Rodríguez, María Esther Farez Vidal
| |
Comparative analysis of lymphoid subsets in peripheral blood and tumor-infiltrating lymphocytes of lung cancer patients
María del Mar Valenzuela-Membrives (Granada, Spain), María del Mar Valenzuela- Membrives, Abel Sanchez- Palencia- Ramos, Francisco Perea- García, Francisco Ruiz-Cabello, Pilar Jimenez, María Esther Farez-Vidal
| |
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Vassiliki Karavana (Athens, Greece), Vassiliki Karavana, Giorgos Kazamias, Anna Panagiotou, Aggeliki Louka, Dimitra Kerdidani, Keli Antonogiannaki, Vassiliki Filaditaki, Charis Roussos, Dimitra Rontogianni, Spyros Zakynthinos, Filio Diamantea, Maria Tsoumakidou
| |
Lung cancer immune cells exhibit inhibited inflammasome response
Aikaterini D. Samara (Athens, Greece), Katerina D. Samara, Ismini Lasithiotaki, Eliza Tsitoura, Ioannis Giannarakis, Anna Psaraki, Eleni Bibaki, Irini Lambiri, Nikolaos Siafakas, Katerina M. Antoniou
| |
Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer
Jurgita Jackute (Kaunas, Lithuania), Jurgita Jackute, Marius Zemaitis, Darius Pranys, Brigita Sitkauskiene, Skaidrius Miliauskas, Raimundas Sakalauskas
| |
CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer
Iwona Osinska (Warsaw, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik
|  |
Determination of antibodies against the red meat derived antigen Neu5Gc in patients with lung cancer. Probable association with disease development and progress
Kelly Domvri (Thessaloniki, Greece), Konstantinos Zarogoulidis, Phaedra Eleftheriou, Kalliopi Domvri, Chrisanthi Chadziyianni, Christos Petrou, Konstantinos Barsamidis, Kyriaki Savidou, Spyridoula Tsitlakidou
| |
MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
Elisa Lappi-Blanco (Oulu, Finland), Elisa Lappi-Blanco, Johanna Mäkinen, Kirsi Laitakari, Shirley Johnson, Riitta Mäkitaro, Risto Bloigu, Siri Lehtonen, Timo Väisänen, Riitta Kaarteenaho
| |
Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer patients
Harry Gosker (Maastricht, Netherlands), Harry Gosker, Celine Op den Kamp, Marco Kelders, Annemarie Dingemans, Ramon Langen, Annemie Schols
| |
Hypoxia-response gene signatures as predictive and prognostic biomarkers in advanced non-squamous non-small cell lung cancer patients
Anca Franzini (St Gallen, Switzerland), Anca Franzini, Florent Baty, Martin Brutsche
| |
Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer
Ioanna Giopanou (Rio, Patras, Greece), Ioanna Giopanou, Ioannis Lilis, Vassilios Papaleonidopoulos, Georgios Stathopoulos
| |
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules
Piotr Kopinski (Bydgoszcz, Poland), Maciej Gawronski, Piotr Kopinski, Marek Jankowski, Arkadiusz Goede, Adam Szpechcinski, Joanna Chorostowska
| |
EGFR mutations determine EGFR-MET crosstalk and MET inhibition in lung cancer
Richard Lee (London, United Kingdom), Richard Lee, Elena Ortiz-Zapater, Gregory Weitsman, Gilbert Fruhwirth, Will Owen, Tony Ng, George Santis
| |
MET genetic lesions in NSCLC are functional markers of early hematogenous spreading and radioresistance
Giulia Stella (Pavia, Italy), Giulia Stella, Rebecca Senetta, Michele Zorzetto, Simona Inghilleri, Ludovica Verdun Di Cantogno, Paolo Comoglio, Paola Cassoni, Federica Meloni
| |
P53 codon 72, GSST1, GSTM1 and CCR5del32 genetic polymorphism: Evidence of correlation between asthma and lung cancer
Mariia Vasileva (Tomsk, Russian Federation), Mariia V. Vasileva, Nadejda V. Cherdyntseva, Polina A. Gervas, Valentina A. Belyavskaya, Vladimir V. Klimov
| |